Edwards Lifesciences Corp Stock Price on March 28, 2024
EW Stock | USD 85.06 0.76 0.90% |
Below is the normalized historical share price chart for Edwards Lifesciences Corp extending back to March 27, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Edwards Lifesciences stands at 85.06, as last reported on the 2nd of May, with the highest price reaching 85.44 and the lowest price hitting 83.81 during the day.
If you're considering investing in Edwards Stock, it is important to understand the factors that can impact its price. Edwards Lifesciences Corp secures Sharpe Ratio (or Efficiency) of -0.0096, which denotes the company had a -0.0096% return per unit of risk over the last 3 months. Edwards Lifesciences Corp exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Edwards Lifesciences' Downside Deviation of 1.29, mean deviation of 1.36, and Coefficient Of Variation of 865.29 to check the risk estimate we provide.
At this time, Edwards Lifesciences' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to climb to about 9.8 B in 2024, despite the fact that Other Stockholder Equity is likely to grow to (2.6 B). . At this time, Edwards Lifesciences' Price To Operating Cash Flows Ratio is fairly stable compared to the past year. Price To Free Cash Flows Ratio is likely to climb to 77.16 in 2024, whereas Price Earnings Ratio is likely to drop 31.34 in 2024. Edwards Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of March 2000 | 200 Day MA 78.533 | 50 Day MA 90.0018 | Beta 1.074 |
Edwards |
Sharpe Ratio = -0.0096
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | EW |
Estimated Market Risk
1.5 actual daily | 13 87% of assets are more volatile |
Expected Return
-0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Edwards Lifesciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Edwards Lifesciences by adding Edwards Lifesciences to a well-diversified portfolio.
Price Book 8.1717 | Enterprise Value Ebitda 30.3262 | Price Sales 9.0498 | Shares Float 596.6 M | Wall Street Target Price 95.48 |
Edwards Lifesciences Main Headline on 28th of March 2024
Disposition of 6320 shares by Lippis Daniel J. of Edwards Li... by Lippis Daniel J.
Filed transaction by Edwards Lifesciences Corp Officer Cvp, Japac. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Edwards Lifesciences Valuation on March 28, 2024
It is possible to determine the worth of Edwards Lifesciences on a given historical date. On March 28, 2024 Edwards was worth 95.48 at the beginning of the trading date compared to the closed value of 95.56. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Edwards Lifesciences stock. Still, in general, we apply an absolute valuation method to find Edwards Lifesciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Edwards Lifesciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Edwards Lifesciences' related companies.
Open | High | Low | Close | Volume | |
93.75 | 95.35 | 93.59 | 95.15 | 3,656,854 | |
03/28/2024 | 95.48 | 96.12 | 94.87 | 95.56 | 4,007,471 |
95.73 | 95.73 | 93.27 | 94.25 | 3,506,287 |
Backtest Edwards Lifesciences | | | Edwards Lifesciences History | | | Edwards Lifesciences Valuation | Previous | Next |
Edwards Lifesciences Trading Date Momentum on March 28, 2024
On April 01 2024 Edwards Lifesciences Corp was traded for 94.25 at the closing time. The highest price during the trading period was 95.73 and the lowest recorded bid was listed for 93.27 . The volume for the day was 3.5 M. This history from April 1, 2024 contributed to the next trading day price decline. The overall trading delta to the next closing price was 1.37% . The overall trading delta to the current price is 3.09% . |
Edwards Lifesciences Corp Fundamentals Correlations and Trends
By evaluating Edwards Lifesciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Edwards Lifesciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Edwards financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Edwards Lifesciences Stock history
Edwards Lifesciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Edwards is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Edwards Lifesciences Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Edwards Lifesciences stock prices may prove useful in developing a viable investing in Edwards Lifesciences
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 609.4 M | 550.8 M | |
Net Income Applicable To Common Shares | 1.8 B | 1.8 B |
Edwards Lifesciences Quarterly Net Working Capital |
|
Edwards Lifesciences Stock Technical Analysis
Edwards Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Edwards Lifesciences Period Price Range
Low | March 28, 2024
| High |
95.48 | 95.56 |
Edwards Lifesciences May 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Edwards Lifesciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Edwards Lifesciences shares will generate the highest return on investment. By undertsting and applying Edwards Lifesciences stock market strength indicators, traders can identify Edwards Lifesciences Corp entry and exit signals to maximize returns
Edwards Lifesciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Edwards Lifesciences' price direction in advance. Along with the technical and fundamental analysis of Edwards Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Edwards to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0812 | |||
Jensen Alpha | 0.1893 | |||
Total Risk Alpha | 0.0814 | |||
Sortino Ratio | 0.1378 | |||
Treynor Ratio | 0.3008 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Stocks Directory Find actively traded stocks across global markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.036 | Earnings Share 2.32 | Revenue Per Share 10.151 | Quarterly Revenue Growth 0.095 | Return On Assets 0.1205 |
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.